Monday, November 14, 2016
- 4:30PM-6:00PM
-
Abstract Number: 2028
Relationship of Limb Length Inequality and Incident and Progressive Knee and Hip Radiographic Osteoarthritis and Symptoms
ACR/ARHP Combined Abstract Session: Epidemiology and Pubic Health- 4:30PM-6:00PM
-
Abstract Number: 2040
Responsiveness of Patient Reported Outcomes Measurement Information System Measures in RA Patients Starting or Switching a DMARD
Quality Measures and Quality of Care I- 4:30PM-6:00PM
-
Abstract Number: 2051
Risk Factors for Cardiovascular Disease Predate the Onset of Symptoms of Rheumatoid Arthritis
Rheumatoid Arthritis – Clinical Aspects III: Prevention of Comorbidity- 4:30PM-6:00PM
-
Abstract Number: 2029
Risk of Knee Pain, Radiographic Osteoarthritis and Knee Arthroplasty in Retired Professional Footballers Compared to the General Population
ACR/ARHP Combined Abstract Session: Epidemiology and Pubic Health- 4:30PM-6:00PM
-
Abstract Number: 2050
Screening for and Management of Comorbidities after a Nurse-Led Program: Results of a 3 Year Longitudinal Study in 776 Established RA Patients
Rheumatoid Arthritis – Clinical Aspects III: Prevention of Comorbidity- 4:30PM-6:00PM
-
Abstract Number: 2059
Serine/Arginine-Rich Splicing Factor 1 (SRSF1) Is a Novel Factor in T Cell Homeostasis and Its Selective Loss in T Cells Causes Autoimmunity and Lupus-like Nephritis
Systemic Lupus Erythematosus – Animal Models- 4:30PM-6:00PM
-
Abstract Number: 2049
Serious Infections in RA Offspring Exposed to Tumor Necrosis Factor Inhibitors
Reproductive Issues in Rheumatic Disorders- 4:30PM-6:00PM
-
Abstract Number: 2061
Successful Treatment of Murine Lupus Nephritis with Helminths Related Tuftsin-Phosphorylcholine Compound and Its Effect on the Microbiota
Systemic Lupus Erythematosus – Animal Models- 4:30PM-6:00PM
-
Abstract Number: 2027
The Association of Light and Moderate-to-Vigorous Walking with Incident Poor Health Outcomes over Two Years in People with or at High Risk of Knee Osteoarthritis
ACR/ARHP Combined Abstract Session: Epidemiology and Pubic Health- 4:30PM-6:00PM
-
Abstract Number: 2046
The Low-Dose Intravenous Cyclophosphamide Euro-Lupus Regimen Does Not Impact the Ovarian Reserve of Lupus Patients, As Measured By Serum Anti-Mullerian Hormone Levels
Reproductive Issues in Rheumatic Disorders- 4:30PM-6:00PM
-
Abstract Number: 2080
Three Simple Tests to Raise the Index of Suspicion for Fibromyalgia in Primary Care
ARHP IV: Clinical Practice, Patient Care and Health Services- 4:30PM-6:00PM
-
Abstract Number: 2057
TLR-7-Mediated Lupus Nephritis Flares Are Independent of Type I Interferon Signaling
Systemic Lupus Erythematosus – Animal Models- 4:30PM-6:00PM
-
Abstract Number: 2068
Type 2 Innate Lymphoid Cells – Cellular Source of Profibrotic Mediators Rapidly and Persistently Recruited in Experimental Fibrosis and Systemic Sclerosis
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics I- 4:30PM-6:00PM
-
Abstract Number: 2041
Validity and Reliability of Patient Reported Outcomes Measurement Information System (PROMIS®) Global Health Short Form in Patients with SLE
Quality Measures and Quality of Care I- 4:30PM-6:00PM
-
Abstract Number: 2036
Whole Exome Sequencing in Early Onset Systemic Lupus Erythematosus